| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 991 |
DO3A-Thiol ；CAS:865470-67-3 DOTA-SH |
5 |
wyh |
2024-11-21 |
| 992 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
7 |
zyl |
2024-11-21 |
| 993 |
Gd-DOTA-HCBP的组成结构 |
4 |
wyh |
2024-11-21 |
| 994 |
双阳离子中心咪唑功能化降冰片烯离子液体单体 ， NB-O-Im+Br--Im+Br- |
9 |
kx |
2024-11-21 |
| 995 |
479081-06-6 ；DOTA-(COOt-Bu)3-NHFmoc-Lys |
6 |
wyh |
2024-11-21 |
| 996 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
7 |
zyl |
2024-11-21 |
| 997 |
DOTA-octreotide的组成与结构 |
6 |
wyh |
2024-11-21 |
| 998 |
endo-N-3,5-双三氟甲基联苯基降冰片烯酰亚胺， endo-PTNDI |
5 |
kx |
2024-11-21 |
| 999 |
DOTA-Octreotide 大环配体奥曲肽 |
5 |
zyl |
2024-11-21 |
| 1000 |
端丙炔基聚乙二醇（PTPEG） |
6 |
WYQ |
2024-11-21 |
| 1001 |
CAS:127985-74-4，DOTA-p-NCS-Bn多肽标记的双功能螯合剂 |
4 |
wyh |
2024-11-21 |
| 1002 |
降冰片烯-异戊二烯共聚物 ，NBE-IP |
6 |
kx |
2024-11-21 |
| 1003 |
cyclo(RGDFK(DOTA))的特性与功能 |
7 |
wyh |
2024-11-21 |
| 1004 |
DOTA-cyclo(RGDfK) |
5 |
zyl |
2024-11-21 |
| 1005 |
Lu-DOTA-TATE；镥-大环配体-TATE多肽 |
10 |
wyh |
2024-11-21 |
| 1006 |
顺-5-降冰片烯-内型-2,3-二羧酸二乙酯 ， endo-NDDE |
8 |
kx |
2024-11-21 |
| 1007 |
DOTA-NCS,DOTA-p-NCS-Bn,cas:127985-74-4 |
8 |
zyl |
2024-11-21 |
| 1008 |
DOTA-PEG-CPP；大环配体DOTA-聚乙二醇-酪蛋白磷酸肽 |
10 |
wyh |
2024-11-21 |
| 1009 |
Gd-DOTA-COOH 钆-四氮杂环配体-羧基 |
7 |
zyl |
2024-11-21 |
| 1010 |
DOTA-E「cyclo(RGDfK)2 |
7 |
wyh |
2024-11-21 |
| 1011 |
DOTA-(Tyr3)-Octreotate；大环配体修饰多肽 |
6 |
wyh |
2024-11-21 |
| 1012 |
单-6-（4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑）-磺酸基-β-CD（PMA-sulfated-β-CD） |
5 |
WYQ |
2024-11-21 |
| 1013 |
碘丙炔基正丁氨基甲酸酯（IPBC） |
8 |
WYQ |
2024-11-21 |
| 1014 |
Gd-DOTA-多肽 |
7 |
zyl |
2024-11-21 |
| 1015 |
DSPE-PEG-DOTA ；二硬脂酰基磷脂酰乙醇胺- 聚乙二醇-大环化合物 |
7 |
wyh |
2024-11-21 |
| 1016 |
250612-06-7 ；DOTA-RGDfK dimer |
4 |
wyh |
2024-11-21 |
| 1017 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
10 |
zyl |
2024-11-21 |
| 1018 |
250612-06-7 DOTA多肽探针二聚体 |
6 |
wyh |
2024-11-21 |
| 1019 |
cas:1262403-90-6 七肽DOTA-VLASSAR |
3 |
zyl |
2024-11-21 |
| 1020 |
DOTA-DGln-DGln-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
4 |
wyh |
2024-11-21 |
| 1021 |
DOTA-NOC ；619300-53-7 |
4 |
wyh |
2024-11-21 |
| 1022 |
DOTA-奥曲肽,DOTA-Octreotide |
6 |
zyl |
2024-11-21 |
| 1023 |
DOTA-PEG5-amine ；DOTA-PEG5-NH2 |
5 |
wyh |
2024-11-21 |
| 1024 |
DOTA修饰肽,1180007-00-4,二肽Z-GGRDOTA |
4 |
zyl |
2024-11-21 |
| 1025 |
DOTA-PEG5-amine ；DOTA-PEG5-NH2 |
4 |
wyh |
2024-11-21 |
| 1026 |
DOTA-RGD,DOTA-cRGDfK |
5 |
zyl |
2024-11-21 |
| 1027 |
DOTA-Lys-Cys-Acid 二肽DOTA-Lys-Cys |
4 |
wyh |
2024-11-21 |
| 1028 |
DOTA-Ala-Ala-COOH ；DOTA-丙氨酸-丙氨酸-羧酸 |
7 |
wyh |
2024-11-21 |
| 1029 |
cas:1293368-74-7,DOTA标记的多肽 |
5 |
zyl |
2024-11-21 |
| 1030 |
Azido-mono-amide-DOTA ；1227407-76-2 |
5 |
wyh |
2024-11-21 |
| 1031 |
Gd-DOTA-HCBP-1(多肽核磁共振成像(MRI)探针) |
4 |
zyl |
2024-11-21 |
| 1032 |
DOTA octreotide,大环配体奥曲肽 |
6 |
zyl |
2024-11-21 |
| 1033 |
DOTA-(D-Gln)3-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2，DOTA修饰多肽 |
7 |
zyl |
2024-11-21 |
| 1034 |
二聚体多肽 cas:250612-06-7 dota-glu[cyclo(arg-gly-asp-d-phe-lys)]2 |
5 |
zyl |
2024-11-21 |
| 1035 |
DBCO-SS-PEG-DOTA 二苯并环辛炔-聚乙二醇之四氮杂环十二烷 |
13 |
zyl |
2024-11-21 |
齐岳微信公众号
官方微信
库存查询